Skip to main content

and
  1. Article

    Open Access

    Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

    The value of genome-wide over targeted driver analyses for predicting clinical outcomes of cancer patients is debated. Here, we report the whole-genome sequencing of 485 chronic lymphocytic leukemia patients e...

    Pauline Robbe, Kate E. Ridout, Dimitrios V. Vavoulis, Helene Dréau in Nature Genetics (2022)

  2. Article

    Open Access

    The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

    Transformation of chronic lymphocytic leukaemia (CLL) to diffuse large B-cell lymphoma (DLCBL) type Richter’s syndrome (RS) carries a dismal prognosis. Standard-of-care chemoimmunotherapy for de novo RS is ina...

    Niamh Appleby, Toby A. Eyre, Maite Cabes, Aimee Jackson, Rebecca Boucher in BMC Cancer (2019)